| 5/12/2015 | BKCVIG | S&P lowers Allergan
|
| 3/17/2015 | BKCVIG | Fitch cuts Allergan, affirms Actavis
|
| 3/13/2015 | BK | Actavis enters into up to $4.7 billion cash bridge credit agreement
|
| 1/8/2015 | BKBWCAHYLMLW | Valeant cuts leverage to 3.5x, holds out prospect of more debt paydowns
|
| 12/22/2014 | BK | Actavis gets $30.9 billion bridge loan, $5 billion term loan for buyout
|
| 11/18/2014 | BK | Actavis gives more details on new debt for Allergan acquisition
|
| 11/17/2014 | BKBWIG | Actavis plans to issue $27.5 billion of new debt at an average of 4.25% to fund Allergan merger
|
| 7/3/2014 | BK | Actavis restates $750 million revolver on acquiring Forest Labs
|
| 7/1/2014 | BKHYIG | Moody's lifts Forest Labs from junk
|
| 7/1/2014 | BKHYIG | Fitch rates Forest Labs BBB-; affirms Actavis
|
| 6/10/2014 | BKIG | Moody's rates Actavis notes Baa3
|
| 6/10/2014 | BKIG | S&P gives Actavis debt BBB-
|
| 6/10/2014 | BKIG | Fitch assigns Actavis bonds BBB-
|
| 4/3/2014 | BK | Actavis gets commitments for $2 billion tranche A-2 term loans
|
| 3/5/2014 | BKIG | S&P rates Actavis loan BBB-
|
| 2/19/2014 | BK | Actavis gets commitment for bridge, term loans to fund Forest merger
|
| 2/19/2014 | BKIG | Actavis gets commitment for bridge, term loans, notes to acquire Forest
|
| 2/18/2014 | BKHYIG | Moody's might upgrade Forest Labs
|
| 2/18/2014 | BKIG | Actavis secures bridge loan for $25 billion acquisition of Forest Labs
|
